Abnormality Re-weighting Strategy

• Abnormality re-weighting is a family of loss re-scaling techniques that recalibrates training signals to emphasize rare or critical samples.
• It integrates token-level, class-level, and sample-level weighting to counterbalance the overrepresentation of normal instances in imbalanced datasets.
• Empirical results demonstrate improved performance in medical imaging and robust regression by fine-tuning hyperparameters and employing meta-learning approaches.

Abnormality re-weighting strategy denotes a family of loss re-scaling approaches that adjust the contribution of training samples or tokens, with the explicit purpose of correcting for bias in representation of abnormal, rare, or clinically significant phenomena. While conceptually originating in the class-imbalance literature, abnormality re-weighting has emerged as a crucial regularization device in domains where standard empirical risk minimization (ERM) unduly prioritizes normal or majority instances, ultimately impairing the sensitivity or fidelity of models to critical rare findings. Applications range from medical vision-language tasks to robust regression and supervised deep learning under noisy or structured data regimes.

1. Motivation and Clinical Context

Radiology and other scientific domains often exhibit a strong “normal-first” or majority-class bias in data distribution or reporting conventions. For instance, radiology reports typically enumerate normal structures first, delaying mention of pathology, with the consequence that LLMs trained under standard autoregressive loss disproportionately learn to generate or prioritize normal findings. This endemic structural bias adversely affects sensitivity to clinically important abnormalities. Analogously, in class-imbalanced datasets or pixel/voxel-wise segmentation of lesions, numerical dominance of normal or large instances suppresses learning signals from minority or small abnormalities, thereby degrading detection and localization (Lai et al., 1 Feb 2026, Nichyporuk et al., 2021, Wang et al., 2023).

2. Core Mathematical Formulation

Abnormality re-weighting modifies the base (typically cross-entropy or regression) loss to incorporate non-uniform sample weights derived from abnormality status, minority-class membership, or outlier properties:

• Token-Level Weighting for Language/Medical Vision In sequence modeling, let $y_1, ..., y_T$ be gold tokens. The SFT (supervised fine-tuning) loss is:

$$\mathcal{L}_{\mathrm{SFT}} = -\sum_{t=1}^T \alpha_t \log P(\hat y_t = y_t)$$

where $\alpha_t = \lambda > 1$ for tokens from abnormal sentences and $\alpha_t = 1$ otherwise (Lai et al., 1 Feb 2026).

• Per-Class Re-Weighting in Imbalanced Learning For class $y$ with empirical prior $\pi_y$, a weighted cross-entropy is:

$$L_{\rm RW}(f(x),y) = -\alpha_y \log\frac{\exp(f(x)_y)}{\sum_{y'}\exp(f(x)_{y'})}$$

With common choices $\alpha_y \propto 1/N_y$, or more generally, $\alpha_y \propto \pi_y^{-\nu}$ (Wang et al., 2023).

• Sample-Level Abnormality and Uniqueness in Regression In regression, the abnormality score $\gamma(x, y)$ is computed as deviation from local mean in target space, and uniqueness $\mu(x, y)$ from spread in input space:

$w(x, y) = \frac{\mu(x, y)}{1 + \gamma(x, y)}$

yielding the re-weighted loss $$\mathrm{VILoss}(x, y, \hat y) = w(x, y) \mathcal{L}(\hat y, y)$$ (Wu et al., 2021).

• Meta-Learned Re-Weighting Functions Meta-Weight-Net parameterizes the sample-weight function $w_i=V(\ell_i;\phi)$ (where $\ell_i$ is per-sample loss) as a learned MLP, optimized by bi-level meta-learning to maximize downstream (meta-set) performance (Shu et al., 2019).

3. Identification of Abnormal or Critical Instances

Abnormality re-weighting requires principled identification of abnormal, rare, or otherwise critical samples:

• Report-Based Token Classification Segment reports into sentences. Use a pre-trained classifier (e.g., Deepseek-V3) to label each as “normal” or “abnormal.” All tokens in abnormal sentences receive up-weight $\lambda$ (Lai et al., 1 Feb 2026).
• Voxel Lesion Size in Segmentation In MRI lesion segmentation, voxels are grouped by lesion instance. Each lesion of size $s_j$ is assigned a weight inversely related to its size, e.g.,

$w(s_j) = 1 + (\alpha/s_j) \exp[-(s_j - 1)/\beta]$

maximizing weights for small lesions and smoothly decaying for large (Nichyporuk et al., 2021).

• Outlierness in Regression Each regression sample’s abnormality is quantified via deviation from local average. Samples with high deviation (potential outliers) are down-weighted (Wu et al., 2021).
• Meta-gradient Signal In meta-weighting frameworks, “abnormal” is context-dependent: samples whose gradient direction aligns with a held-out meta-set are up-weighted, others are suppressed (Shu et al., 2019).

4. Hyperparameters and Implementation Protocols

Implementation involves selection and tuning of weighting factors and associated hyperparameters:

• Abnormality Weight Factor ($\lambda$) In Med3D-R1, optimal performance was achieved at $\lambda=1.10$ (abnormal tokens ×1.10), with the weight entering directly without normalization or clipping (Lai et al., 1 Feb 2026).
• Lesion Size Re-weighting ($\alpha, \beta$) For lesion segmentation, default hyperparameters are $\alpha = \beta = 4$, empirically validated to stabilize gradients and preserve segmentation accuracy (Nichyporuk et al., 2021).
• Class Re-weighting Exponent ($\nu$) and Logit-Adjustment ($\tau$) Imbalanced learning strategies tune $\nu$ (power law for $\alpha_y$) and logit bias parameter $\tau$ (Wang et al., 2023).
• Meta-weight Learning Rates ($\alpha, \beta$) Meta-Weight-Net alternates learning of model and weighting-network, with explicit step sizes for each update sequence (Shu et al., 2019).

The following table summarizes the critical hyperparameters by setting:

Strategy	Key Hyperparameters	Value(s)
Med3D-R1 ARW (Lai et al., 1 Feb 2026)	$\lambda$	$1.10$
Lesion Size Re-weighting (Nichyporuk et al., 2021)	$\alpha, \beta$	$4, 4$
Imbalanced learning (Wang et al., 2023)	$\nu, \tau, T_0$	task-specific
VILoss (Wu et al., 2021)	partition $\lambda$	maximize LD
Meta-Weight-Net (Shu et al., 2019)	MLP arch., $\alpha, \beta$	fixed, tuned

5. Empirical Impact and Results

Empirical validation across multiple domains consistently demonstrates that abnormality re-weighting improves model fidelity to rare or clinically critical classes, robustifies against structural bias, and stabilizes operating points:

• Medical Vision-Language In Med3D-R1, ablation shows ARW improves CIDEr from 20.22 to 23.86 (+3.64), BLEU-1 from 38.51 to 40.93 (+2.42), and METEOR from 35.16 to 36.18 (+1.02). Removal of ARW reduces mean metric from 43.53% to 42.07%, confirming utility in pathology description and bias mitigation (Lai et al., 1 Feb 2026).
• Lesion Detection Lesion-size re-weighting (BCE+LSR) sharpens small-lesion sensitivity while maintaining large-lesion Dice. It also aligns optimal segmentation and detection thresholds (operating points), streamlining clinical deployment (Nichyporuk et al., 2021).
• Imbalanced Classification and Regression Unified re-weighting schemes provide statistically tighter generalization guarantees, with the Rademacher complexity “contracted” by class-specific factors, and empirical risk terms improved for minorities (Wang et al., 2023). For regression, VILoss reduces outlier impact and mean absolute percentage error (MAPE) by up to 60% on synthetic benchmarks, and achieves substantial gains (+1–5 precision/F1) in noisy logistic regression settings (Wu et al., 2021).
• Meta-Learned Weighting Meta-Weight-Net outperforms fixed re-weighting: on CIFAR-10 with 100× class imbalance, accuracy rises to 75.2% (vs. 70.4% for regular CE); for noisy labels, Meta-Weight-Net suppresses outliers, adaptively interpolating between “focal” and “self-paced” weighting shapes (Shu et al., 2019).

6. Extensions, Limitations, and Practical Guidelines

Current strategies underscore the necessity of careful normalization (to avoid extreme gradients), use of domain-appropriate abnormality criteria, and empirical validation on held-out sets. Abnormality re-weighting is sensitive to hyperparameter regimes: excessive boosting of abnormal samples can destabilize training (e.g., $\alpha \gg \beta$ in BCE+LSR); conversely, overly weak re-weighting forfeits sensitivity gains. Deferred or two-stage scheduling further enhances stability by delaying re-weighting until initial model fit stabilizes (Wang et al., 2023).

Generalization analysis confirms that abnormality re-weighting improves both empirical and theoretical risk for minority or abnormal classes, provided local Lipschitz constants and empirical priors are adequately estimated. In regression, a plausible implication is that further combining abnormality control with feature-space uniqueness metrics can selectively prioritize information-rich, reliable portions of the data.

Emerging research suggests abnormality re-weighting will be central in robustifying both large-scale supervised and semi-supervised learning, particularly as applications shift toward safety-critical or heavily skewed domains. Key open directions include extension to multi-modal settings, hierarchical structures (e.g., multi-class/multi-lesion), and meta-adaptive strategies that learn the abnormality measure itself.